US Broker Ratings

Mineralys Therapeutics, Inc. (MLYS): Analyst Ratings Signal 86.77% Potential Upside for Biotech Innovator

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a dynamic player in the biotechnology sector, is capturing investor attention with a promising potential upside of 86.77%, as per recent..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring a 17.48% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector, capturing the attention of investors with its promising financial outlook and robust product portfolio...

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotech Gem with Over 100% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, is capturing significant investor interest with its promising pipeline of treatments for immunological diseases...

The Pennant Group, Inc. (PNTG) Stock Analysis: Impressive Revenue Growth and Analyst Consensus Point to Upside

Investors looking at The Pennant Group, Inc. (PNTG) might find themselves intrigued by its robust revenue growth and favorable analyst ratings, which suggest a potential upside...

Crinetics Pharmaceuticals, Inc. (CRNX): Analyst Consensus Reveals 118% Potential Upside for Rare Disease Therapeutics

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is carving a niche in the biotechnology sector with its focus on developing therapeutics for rare endocrine diseases and endocrine-related tumors...

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 180% Upside Amidst Challenging Financials

Opko Health, Inc. (NASDAQ: OPK) presents a fascinating case for investors intrigued by the healthcare sector’s dynamic landscape. While the company faces significant financial headwinds, compelling..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook with an 18.3% Upside Potential

Investors seeking opportunities in the healthcare sector should take a closer look at Aurinia Pharmaceuticals Inc (AUPH), a Canadian biopharmaceutical company that is making strides in..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 30% Upside in the Medical Device Sector

For investors eyeing the healthcare sector, particularly the medical devices industry, Establishment Labs Holdings Inc (NASDAQ: ESTA) represents a compelling prospect. This Austin-based company, with a..

BGM Group Ltd. (BGM): Investor Outlook on a Healthcare Stock with a 52-Week Range Highlighting High Volatility

BGM Group Ltd. (BGM), a Chinese company in the healthcare sector, specializes in manufacturing and distributing active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Navigating a 147% Potential Upside in the Biotech Arena

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a prominent player in the healthcare sector, particularly in the niche of drug manufacturing for specialty and generic medications, has captured..

Omnicell, Inc. (OMCL) Investor Outlook: 44% Potential Upside Beckons Savvy Investors

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, offers a compelling opportunity for investors seeking exposure to innovative health information services. Despite..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 218% Upside Opportunity

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical company specializing in treatments for severe allergic reactions, is currently on the radar of individual investors looking for high-upside..

Certara, Inc. (CERT) Stock Analysis: Exploring a 36% Potential Upside for Investors

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, particularly within the health information services industry, is capturing investor attention with a notable 36.42%..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 29% Potential Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling case. This Houston-based company operates outpatient physical therapy clinics..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 58% Upside Potential

For investors with an eye on the healthcare sector, Integra LifeSciences Holdings Corporation (NASDAQ: IART) offers intriguing prospects. Despite current challenges, the potential upside of 58.05%..

Dyne Therapeutics, Inc. (DYN) Investor Outlook: Exploring a Potential 115% Upside in Biotech

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to developing therapeutics for neuromuscular diseases...

Artivion, Inc. (AORT) Stock Analysis: Exploring a 42.5% Potential Upside in the Medical Devices Sector

Artivion, Inc. (NYSE: AORT), a prominent player in the medical devices industry, has been garnering attention from investors due to its robust growth potential and strategic..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Biotech Gem with 40.86% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has recently captured the attention of investors with its promising pipeline in the healthcare sector, specializing in biotechnology. With a market..

Teladoc Health, Inc. (TDOC) Investor Outlook: Assessing the 34.82% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) stands at a fascinating juncture in the healthcare industry as it continues to solidify its position in the burgeoning field of..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 65% Upside Potential in the Healthcare Sector

For investors seeking opportunities within the healthcare sector, Perrigo Company plc (NYSE: PRGO) offers a compelling case. With its current stock price at $10.29 and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds